Vein Awareness

The past decade has been marked with new advances in the treatment of varicose veins and spider veins. These advances in leg health have followed with new technologies that have been developed for diagnosis and treatment. Ultrasound technology and laser and radiofrequency energy technology have made treatment easier on the patient and the doctor. The patient can now be treated as an outpatient under local anesthesia and can return to normal activity immediately after surgery. These advances have eliminated the need for hospital treatment and have resulted in patient-friendly care. The treatments are nearly painless and are done in the office in 30 minutes.

Frequently, we find that patients and even practicing physicians are still not aware of the new treatment breakthroughs. In fact, a new subspecialty of medicine called the American Board of Venous and Lymphatic Disease was started in 2008. The specialized physicians are trained and qualified to help patients understand the significance of their vein problems and how they can be treated.

Vein problems are considered both health issues and cosmetic issues. They are medically significant because they can cause symptoms and disability. Over 25 million people in the United States suffer from the effects of venous disease, making it the most prevalent vascular disease affecting both men and women in the United States. Many patients have assumed that leg pain is just part of aging. Sometimes the pain is so severe it limits their lifestyle, but they have learned to live with it and tolerate the symptoms. But leg pain is not normal. It has been rewarding to meet these patients and be able to change their lifestyles and help them live better.
Leg pain and symptoms such as aching and heaviness with prolonged standing and daily activity are not normal. Other symptoms include fatigue, cramps, itching, and burning. Some patients experience restless legs associated with the inability to sleep well because of an uncomfortable feeling in the legs. These are all symptoms of broken veins which can be treated easily.

The symptoms that at first may be mild can progress with time and become more severe. They start when major veins in the legs malfunction because of either heredity or lifestyle, such as pregnancies, prolonged standing and sitting, or injuries to the legs. As a result, the veins that should direct the blood flow to the heart with valves that prevent backflow begin to leak and blood starts slowing down in the legs, moving away from the heart. This causes pooling and pressure in the leg veins, creating distension and dilation. Varicose veins and spider veins are related to increased pressure in the veins. As the disease progresses, the patient notices swelling and skin changes associated with the increased pressure in the veins. The adverse changes can also lead to blood clots in the legs known as deep vein thrombosis (DVT). This condition can be life threatening, resulting in pulmonary embolus.

These problems are all treatable and preventable, especially if the condition is caught in the early stage of disease development. Trained vein specialists are experts at diagnosis and in the treatment of all vein diseases, which can be done within the ambulatory clinic setting in 15 to 30 minutes. In fact, most of the procedures are covered by insurance.

One of the new advances is called thermal ablation, which treats the broken vein with heat and stops the abnormal flow of blood in the veins. This results in a normal blood flow in the leg and better leg health and improvement of symptoms. This treatment can be done with local anesthesia, and the patient can walk out after treatment and return to normal activity the next day. One of my patients whom we treated could stand and walk for only 10 minutes at a time before treatment because of the pain and discomfort. After treatment, the patient was able to be fully active all day without discomfort. I have had patients tell me that their first night of sleep in years was when we treated their varicose veins and the restless leg symptoms resolved immediately. In fact, patient satisfaction is high at about 95%, which is very rewarding to me.

The cosmetic results are also significant. Patients get an immediate symptomatic improvement from treating just one major nonfunctioning vein. The patient can then have follow-up treatment for smaller, less symptomatic but cosmetically worrisome veins. These patients want to treat the smaller spider veins so they can wear dresses and show off their legs. This treatment can be done easily with minimal discomfort, and a return to work right away. Sclerotherapy is the main procedure for spider veins and is very effective.
I would encourage patients with these conditions to seek out a vein specialist to improve their lives and to have healthy legs again.

This post was written by Vein and Skin Laser Center | September 30, 2013

The Industry Standard for Aesthetic & Botox Training

The IAPAM is where the world’s physicians come together to obtain Internationally recognized Aesthetic Medicine Certification. Our expert faculty of dermatologists will guide you with the latest techniques during our Hands-On CME Botox Training programs, Laser Training, Chemical Peel Training, Weight Loss Training, or one of our other hands-on aesthetic training programs.

This post was written by Vein and Skin Laser Center | September 4, 2013

Lumenis – As shown on The Today Show!


New York, NY, May 28, 2009 – Following the feature of the UltraPulse CO2 fractional laser as a Miracle Treatment for Burn Scars on The Today Show, The Insider will also be featuring the treatment tonight, check your local listings for the time.

Chandra, Jordan and Trae Berns were interviewed today by The Insider. The interview focused on how and when they got their burns they have lived with for 20 years. The girls also discussed their journey through the treatment process with Dr. Jill Waibel, the treating physician. Specifically, they discussed how the Lumenis UltraPulse Laser has helped to minimize both the unwanted color and roughness of their scars. Lastly, they expressed their happiness in the results of the treatments thus far and look forward to additional treatments and results in the next 3 months.

Dr. Jill Waibel was also interviewed for the segment, in which she discussed the fractional treatment she performed on the girls using the Lumenis laser. Specifically, Dr. Waibel talked about the TotalFX, ActiveFX and DeepFX treatments that were used on the girl’s burn scars.

Lumenis pioneered skin resurfacing over 18 years ago with its C02 lasers. The Lumenis UltraPulse laser system has FDA clearance for more than 34 indications and is referenced in excess of 90 peer-reviewed publications. Although frequently used for aesthetic applications, the UltraPulse offers 240 watts of power and microsecond pulses which combined provide a broad canvas from which other treatments in cutaneous surgical and aesthetic applications can be provided.

The entire story of the Berns triplets and their treatments using the UltraPulse Fractional CO2 laser can be found at

About Lumenis

Lumenis Ltd,. a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, is Israel’s largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems.

Article: Lumenis – As shown on The Today Show!

This post was written by Vein and Skin Laser Center | September 4, 2013

Lumenis® Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting

Lumenis® Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting

Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, unveiled two new laser innovations at the American Academy of Dermatology (AAD) annual meeting in San Francisco, California which specifically address economic challenges facing the cosmetic industry. The LightSheer® Duet™ Diode Laser System and the UltraPulse 4X CO2 Laser System offer significant cost-saving advantages that enable affordable hair removal and fractional resurfacing despite challenging economic times.

“The cosmetic industry is certainly feeling the effects of the economy and the resulting decline in elective, fee-per-service procedures. We have focused our development efforts on time and cost saving innovations that will provide physicians with innovative and competitive solutions that can sustain, differentiate and grow their business during challenging times”, said Mr. Robert Mann, General Manager of Lumenis Global Aesthetics and Dermatology.

The LightSheer Duet reduces hair removal treatment times by up to 75% and vastly improves patient comfort, eliminating the need for topical anesthetics, while the UltraPulse CO2 Laser System delivers ActiveFX, DeepFX and TotalFX fractional resurfacing in a single treatment with only a single pass. The new UltraPulse 4X upgrade now covers twice the treatment area and twice the speed. These ground-breaking changes significantly improve practitioner and patient acceptance of hair removal and fractional resurfacing, as well as increase the revenue potential for physician practices and clinics.

“While consumers are still spending money on cosmetic treatments, their requirements regarding cost and value have certainly changed. Patients are more willing to invest in treatments that can be done more quickly, with little pain and short recovery times. The new LightSheer Duet and the UltraPulse DeepFX 4X fit precisely into this category and provide me a critical competitive advantage of attracting patients to my practice.” said Dr. Mitchel Goldman, Medical Director, La Jolla SPA MD


Lumenis C02 Laser Systems pioneered resurfacing more than 18 years ago and the UltraPulse laser system is FDA-cleared for more than 34 indications and has been referenced in more than 90 peer-reviewed publications. UltraPulse has led the way in fractional resurfacing with the introduction of ActiveFX, DeepFX and TotalFX treatments. The unique micro-second pulsing properties of UltraPulse allow efficient ablation, lower downtime and more comfortable treatment. The UltraPulse 4X now covers twice the surface area per scan, expanding from 7x7mm to 10x10mm and delivers twice the pulse speed, from 300Hz to 600Hz.


Lumenis is Israel’s largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems.

For more information about Lumenis and its products, log onto

Lumenis® is a registered trademark of Lumenis Ltd.

LightSheer® Duet™ is a trademark of Lumenis Ltd.

UltraPulse® is a trademark of Lumenis Ltd.


Michelle Maydan

Director of Corporate Communications





Article: Lumenis® Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD)

This post was written by Vein and Skin Laser Center | September 4, 2013

View Dr. Fern’s Hospital Award Display!

David Fern, MD, has practiced medicine since 1971 and has been a DeKalb Medical Surgeon since 1978. As part of his mission to serve others, Dr. Fern joined “Heart for Africa” and has traveled to South Africa and Kenya to provide free medical care. His most recent trip was to Kenya in November 2007.


This post was written by Vein and Skin Laser Center | September 4, 2013

DeepFX™ and ActiveFX™fractional resurfacing

DeepFX™ and ActiveFX™ fractional resurfacing featured at annual meeting of the American Society of Aesthetic Plastic Surgery

DeepFX and ActiveFX were featured during this year’s annual meeting of The American Society of Aesthetic Plastic Surgery (ASAPS) in San Diego during the Cosmetic Medicine course, chaired by Jeffrey Kenkel, MD of UTSW.

Dr. Kenkel has been using the fractional ActiveFX technology for more than two years, and commented about Lumenis’ latest technological advancement. “I’m excited about this new generation of CO2 devices because I can offer my patients a single treatment that provides desired results with manageable downtime.” Dr. Kenkel said.

Michael Kulick, MD, of San Francisco showcased DeepFX at the full-daycourse. Dr. Kulick performed a live DeepFX treatment, answering audience questions regarding pre- and post-treatment protocols, depth of penetration, and optimal settings. He noted that his patient felt little to no discomfort with the treatment, and had less post-operative side effects than other fractional devices that were presented.

Deep FX, the latest in fractional treatment offered by Lumenis Inc., joins the already popular ActiveFX as a powerful way to treat wrinkles, scars, skin tone and texture in a single treatment with minimum downtime.

ActiveFX targets the epidermal and papillary dermal layers of the skin and is ideal for treating conditions that manifest in the upper layers of the skin, including fine lines, dyschromia, and textural irregularities. DeepFX, which was introduced in 2007, targets the deep dermal layers of the skin, and provides exceptional results on deep wrinkles, scars, and peri-oral rhytids.

“The UltraPulse Encore, is the only system with both DeepFX and ActiveFX resurfacing options, providing physicians the most versatile CO2 laser in the industry” commented Dale Koop, Sr. Vice President and head of Lumenis’ Strategic Aesthetic Business Unit. “Long known as the ‘gold standard’ in the industry, the UltraPulse Encore is a shining example of Lumenis’ commitment to the ongoing development and commercialization of premium lasers to our physician customers”

Both the ActiveFX and DeepFX treatments gained widespread interest at this ASAPS meeting. Jordan Farkas, MD, presented four talks that included the dramatic histologic effects of ActiveFX and DeepFX. Dr. Farkas, who has completed extensive research on fractional technology, was awarded with this year’s Research Paper of the Year for his work. Kenneth Rothaus, MD, FACS, also presented on Lumenis’ fractional technology, and featured ActiveFX and DeepFX at the “Hot Topics in Cosmetic Surgery” discussion.

In the ASAPS meeting’s Scientific Session, “Fractional Resurfacing — A Critical Assessment,” a report on the clinical outcomes and histopathological results of ActiveFX and DeepFX, were presented by Dr. Jeffrey Kenkel. Dr. Kenkel also noted that he likes to combine the Lumenis fractional treatments. “Most patients have superficial and deep needs, so I often combine ActiveFX and DeepFX,” he said. He presented photos of his patients that received the treatments, and remarked on the exceptional results that had been achieved.


Lumenis is Israel’s largest medical device company with more than 1,000 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. In December 2006, a group led by a private equity consortium LM Partners LP and Ofer Hi-Tech Group invested approximately $150 million in the Company.


Michelle Maydan

Director of Corporate Communications




Lumenis® is a registered trademark of Lumenis Ltd.


Article: DeepFX™ and ActiveFX™fractional resurfacing

This post was written by Vein and Skin Laser Center | September 4, 2013

Dr. David Richard Fern Earns Certification by the American Board of Phlebology

Atlanta, Georgia August 5, 2008 – The American Board of Phlebology has announced that David R. Fern has earned board certification in the specialty of phlebology by the American Board of Phlebology. Dr. David R. Fern was board certified by the ABPh in July 2008. This is the charter class for ABPh, which includes 248 diplomates nationwide.

We are very pleased to announce this important accomplishment by Dr. Fern. His certification with the American Board of Phlebology reflects his knowledge and experience in providing patient care.

To become an ABPh diplomate, an applicant must complete the requisite training or experience qualifications, meet the continuing medical education requisites, and pass a stringent certification examination. Certification periods are ten years and maintenance will be dependent on the ability of the diplomate to display competency in four areas of assessment: evidence of professional standing, evidence of commitment to lifelong-learning and periodic self-assessment, evidence of cognitive expertise, evaluation of performance in practice.

Dr. David R. Fern is the founder and director of Vein and Skin Laser Center. He is board certified by the American Board of Surgery and a Fellow of the American College of Surgeons. Dr. Fern is associated with Dekalb Surgical Associates.

The American Board of Phlebology ( is an independent, non-profit organization founded in 2007 for the purpose of certifying physicians who have met a defined standard of education, training and knowledge in the field of phlebology. The American Board of Phlebology (ABPh) was established to;

1. Improve the standards of medical practitioners and the quality of patient care related to the treatment of venous disorders and all aspects of venous disease

2. Serve the public and the medical profession by establishing initial and continuing qualifications for certification and maintenance of certification as physician specialists in the practice of phlebology

3. Examine physician candidates for certification and maintenance of certification in the practice of phlebology

4. Establish educational standards for teaching and training programs in phlebology

5. Maintain a registry of individuals who hold certificates issued by the Board

For more information, visit American Board Of Phlebology


Article: Dr. David Richard Fern Earns Certification by the American Board of Phlebology

This post was written by Vein and Skin Laser Center | September 4, 2013

Dr. Fern Listed as “Top Board Certified Physician”

David R. Fern, MD, FACS


980 Johnson Ferry Road, Suite 430 Atlanta, GA 30342

2665 N. Decatur Road, Suite 730 Decatur, GA 30033




Board Certifications:  Fellow, American College of Surgeons;

American Board of Phlebology – Charter Class Vein Surgery

Medical Degree:  Emory University School of Medicine;

Residency: Emory University School of Medicine – General Surgery Residency at Emory, Crawford Long and Grady Hospitals;

Member American Society of Breast Surgeons



Veins: Varicose & Perforating (VNUS Closure); Spider (schlerotherapy & laser)

Wrinkled, sundamaged skin: CO2 Laser Resurfacing (Active FX by Lumenis) and Photorejuvenation (IPL by Lumenis)

Skin Cancer

Botox, Juvederm and Radiesse tissue fillers



David Fern, founder and medical director of Vein & Skin Laser Center, has been involved in the treatment of skin diseases, skin cancer, melanoma, breast cancer and vein surgery for 30 years. His training and experience in general, cancer and trauma surgery has required that he be profi cient in the diagnosis and treatment of vascular and skin diseases and injuries. His patients use the words caring, skilled and kind. “I was extremely impressed with the results. Dr. Fern is caring and extremely skilled. His staff is really the best I’ve seen in the city.” Come in and experience for yourself the high level of patient satisfaction that Dr. Fern’s patients enjoy.


Article: “Dr. Fern Listed as Top Board Certified Physician”

This post was written by Vein and Skin Laser Center | September 4, 2013